# US 2021/0276975 A1 · Inhibitors of (alpha-v)(beta-6) integrin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0276975 A1
- Document ID: US20210276975A1
- Status: Published application
- Kind: A1
- Application number: 17/314,777
- Filed: 2021-05-07
- Published: 2021-09-09
- Earliest claimed: 2017-02-28
- Assignees: Morphic Therapeutic, Inc.
- Applicants: Morphic Therapeutic, Inc.
- Inventors: Mark Brewer; Matthew G. Bursavich; Aleksey I. Gerasyuto; Kristopher N. Hahn; Bryce A. Harrison; Kyle D. Konze; Fu-Yang Lin; Blaise S. Lippa; Alexey A. Lugovskoy; Bruce N. Rogers; Mats A. Svensson; Dawn M. Troast
- Web page: https://patentgrep.com/patent/US20210276975A1

## CPC

- C07D 401/12: linked by a chain containing hetero atoms as chain links
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/12: of the kidneys
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 37/02: Immunomodulators
- C07D 471/04: Ortho-condensed systems
- C07D 471/08: Bridged systems
- C07D 487/08: Bridged systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed are small molecule inhibitors of αvβ6 integrin, and methods of using them to treat a number of diseases and conditions.

## Claims

### Claim 1

A compound of formula (I):
A-B—C (I)
wherein:
A is
B is alkylene-N(R)C(O)—, -alkylene-(heterocyclyl)-C(O)—, alkylene-C(O)N(R)—, or heterocyclyl-C(O)—;
C is
wherein
each n′ is 0, 1 or 2;
R2 is H, alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, cycloalkyl, -alkylene-alkoxy, alkylene-aryl, or heterocycloalkyl;
R3, is H, halide, CF3, alkyl, alkylene-alkoxy, aryl, hydroxyl, or alkoxy;
R6 is H, halide, CF3, alkyl, alkylene-alkoxy, aryl, hydroxyl, or alkoxy; and
R7 is H, halide, CF3, alkyl, alkylene-alkoxy, aryl, hydroxyl, or alkoxy;
R is H, alkyl, or aryl;
each R1 is independently H, alkyl, halide, alkoxy, CF3, OH, alkylene-OH, NO2, —N(H)R, or NH2;
provided each instance of R1 and R2 are not all simultaneously H.

### Claim 2 (depends on 1)

The compound of claim 1, wherein C is

### Claim 3 (depends on 1)

The compound of claim 1, wherein one or both of R6 and R7 is H.

### Claim 4 (depends on 3)

The compound of claim 3, wherein R3 is H, halide, Me, or OMe.

### Claim 5 (depends on 1)

The compound of claim 1, wherein R3, is H.

### Claim 6 (depends on 2)

The compound of claim 2, wherein R3, R6 and R7 are each H.

### Claim 7 (depends on 1)

The compound of claim 1, wherein at least one instance of R1 is alkyl, halide, OMe, OH, alkylene-OH, or NH2.

### Claim 8 (depends on 1)

The compound of claim 1, wherein at least one instance of R1 is alkyl, or halide.

### Claim 9 (depends on 1)

The compound of claim 1, wherein all instances of R1 are H.

### Claim 10 (depends on 1)

The compound of claim 1, wherein B is selected from the group consisting of:
wherein
R is H or Me;
m is 0, 1, 2, or 3; and
n is 0, or 1.

### Claim 11 (depends on 10)

The compound of claim 10, wherein R2 is H.

### Claim 12 (depends on 1)

The compound of claim 1, wherein R2 is (C1-C4)alkyl, cyclopropyl, CH2OMe, phenyl, —CH2Ph, pyridinyl, or indolyl.

### Claim 13 (depends on 12)

The compound of claim 12, wherein R2 is Me.

### Claim 14 (depends on 12)

The compound of claim 12, wherein R2 is phenyl or pyridinyl.

### Claim 15 (depends on 14)

The compound of claim 14, wherein the phenyl at R2 is substituted with one or more independent instances of alkoxy, OH, halide, —N(H)C(O)alkyl, —C(O)NH2, or —C(O)alkyl; and wherein the pyridinyl at R2 is substituted with NH2, or OH.

### Claim 16 (depends on 12)

The compound of claim 12, wherein R2 is

### Claim 17 (depends on 2)

The compound of claim 2, wherein A is

### Claim 18 (depends on 1)

The compound of claim 1, wherein:
a. A is
b. B is alkylene-N(R)C(O)—, -alkylene-(heterocyclyl)-C(O)—, alkylene-C(O)N(R)—, or heterocyclyl-C(O), wherein R is H or methyl, and alkylene in B is propyl or butyl;
c. C is
and R3 is H, halide, Me, or OMe.

### Claim 19 (depends on 18)

The compound of claim 18, wherein B is selected from the group consisting of:
wherein n is 0 or 1 and m is 2 or 3; and R3 is H or F, and R2 is selected from the group consisting of: alkyl, unsubstituted phenyl, and phenyl substituted with one or more independent instances of alkyl, alkoxy, or halide.

### Claim 20 (depends on 1)

The compound of claim 1, wherein
a. at least one instance of R1 is Me, halide, OMe, OH, alkylene-OH, or NH2; and
b. B is -alkylene-N(R)C(O)—, -alkylene-C(O)N(R)—, or
wherein alkylene in B is propyl or butyl, R is H or methyl, and n is 0 or 1;
C is
and
R3 is H, halide, Me, or OMe.
